Roger Silvestrini

2.0k total citations
20 papers, 1.1k citations indexed

About

Roger Silvestrini is a scholar working on Rheumatology, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Roger Silvestrini has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Rheumatology, 6 papers in Pathology and Forensic Medicine and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Roger Silvestrini's work include Systemic Lupus Erythematosus Research (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Autoimmune Bullous Skin Diseases (4 papers). Roger Silvestrini is often cited by papers focused on Systemic Lupus Erythematosus Research (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Autoimmune Bullous Skin Diseases (4 papers). Roger Silvestrini collaborates with scholars based in Australia and United Kingdom. Roger Silvestrini's co-authors include Emmanuel J. Favaloro, Elizabeth M. Benson, Judy Savige, Wendy Pollock, Bill Paspaliaris, D.J.G. Davies, J. Charles Jennette, David Gillis, David Jayne and Vincent Esnault and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Diabetologia and Journal of Clinical Pathology.

In The Last Decade

Roger Silvestrini

20 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roger Silvestrini Australia 13 556 353 210 183 170 20 1.1k
F. Maurier France 20 458 0.8× 751 2.1× 154 0.7× 262 1.4× 109 0.6× 57 1.3k
E. L. Matteson United States 19 683 1.2× 967 2.7× 286 1.4× 161 0.9× 170 1.0× 36 1.6k
Curry L. Koening United States 22 889 1.6× 544 1.5× 237 1.1× 249 1.4× 141 0.8× 43 1.4k
Lillian Barra Canada 18 373 0.7× 658 1.9× 127 0.6× 322 1.8× 92 0.5× 53 1.2k
R. Pérez-Álvarez Spain 19 488 0.9× 599 1.7× 640 3.0× 302 1.7× 185 1.1× 25 1.6k
Cándido Díaz‐Lagares Spain 19 277 0.5× 704 2.0× 420 2.0× 357 2.0× 153 0.9× 25 1.5k
J. Schmidt France 15 764 1.4× 476 1.3× 150 0.7× 196 1.1× 156 0.9× 58 1.1k
José María Pego‐Reigosa Spain 22 333 0.6× 959 2.7× 259 1.2× 503 2.7× 142 0.8× 82 1.6k
M J Cuadrado United Kingdom 13 253 0.5× 814 2.3× 135 0.6× 403 2.2× 79 0.5× 21 1.4k
Sung Soo Ahn South Korea 19 473 0.9× 431 1.2× 163 0.8× 265 1.4× 197 1.2× 156 1.2k

Countries citing papers authored by Roger Silvestrini

Since Specialization
Citations

This map shows the geographic impact of Roger Silvestrini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Silvestrini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Silvestrini more than expected).

Fields of papers citing papers by Roger Silvestrini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger Silvestrini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Silvestrini. The network helps show where Roger Silvestrini may publish in the future.

Co-authorship network of co-authors of Roger Silvestrini

This figure shows the co-authorship network connecting the top 25 collaborators of Roger Silvestrini. A scholar is included among the top collaborators of Roger Silvestrini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger Silvestrini. Roger Silvestrini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Prain, Kerri, Mark Woodhall, Angela Vincent, et al.. (2019). AQP4 Antibody Assay Sensitivity Comparison in the Era of the 2015 Diagnostic Criteria for NMOSD. Frontiers in Neurology. 10. 1028–1028. 51 indexed citations
2.
Brown, David A., Sudarshini Ramanathan, Roger Silvestrini, et al.. (2018). Potential surrogate markers of central nervous system inflammation in cerebrospinal fluid in the diagnosis of autoimmune encephalitis. Neurology Psychiatry and Brain Research. 29. 6–7. 1 indexed citations
3.
Silvestrini, Roger, et al.. (2016). Validation of a phospholipase A2 receptor antibody ELISA in an Australian cohort with membranous glomerulonephritis. Pathology. 48(3). 242–246. 11 indexed citations
4.
Silvestrini, Roger, et al.. (2016). Comparison of two extractable nuclear antigen testing algorithms: ALBIA versus ELISA/line immunoassay. Pathology. 48(5). 491–497. 6 indexed citations
5.
Kelly, Shane, et al.. (2014). Comparative study of five serological assays for the diagnosis of paraneoplastic pemphigus. Pathology. 47(1). 58–61. 11 indexed citations
6.
Lin, Ming‐Wei, et al.. (2014). A Dual-Fixed Neutrophil Substrate Improves Interpretation of Antineutrophil Cytoplasmic Antibodies by Indirect Immunofluorescence. American Journal of Clinical Pathology. 142(3). 325–330. 12 indexed citations
7.
Kelly, Shane, et al.. (2014). Utility of serological assays in the diagnosis of paraneoplastic pemphigus. Pathology. 46. S38–S39. 1 indexed citations
8.
Silvestrini, Roger, et al.. (2010). False-positive intercellular cement substance antibodies due to group A/B red cell antibodies: frequency and approach. Pathology. 42(6). 574–577. 13 indexed citations
9.
Bozinovski, Steven, Anastasia Hutchinson, Michelle Thompson, et al.. (2007). Serum Amyloid A Is a Biomarker of Acute Exacerbations of Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 177(3). 269–278. 208 indexed citations
10.
Favaloro, Emmanuel J., et al.. (2005). A Multilaboratory Peer Assessment Quality Assurance Program-Based Evaluation of Anticardiolipin Antibody, and beta2-Glycoprotein I Antibody Testing. Seminars in Thrombosis and Hemostasis. 31(1). 73–84. 30 indexed citations
11.
Bell, Katy, et al.. (2003). Procalcitonin: A Marker of Bacteraemia in SIRS. Anaesthesia and Intensive Care. 31(6). 629–636. 42 indexed citations
12.
Favaloro, Emmanuel J. & Roger Silvestrini. (2002). Assessing the Usefulness of Anticardiolipin Antibody Assays. American Journal of Clinical Pathology. 118(4). 548–557. 61 indexed citations
13.
Silvestrini, Roger & Elizabeth M. Benson. (2001). Whither smooth muscle antibodies in the third millennium?. Journal of Clinical Pathology. 54(9). 677–678. 12 indexed citations
14.
Savige, Judy, David Gillis, Elizabeth M. Benson, et al.. (1999). International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA). American Journal of Clinical Pathology. 111(4). 507–513. 417 indexed citations
15.
16.
Jolles, Stephen, et al.. (1999). Atypical C-ANCA following high dose intravenous immunoglobulin.. Journal of Clinical Pathology. 52(3). 177–180. 10 indexed citations
17.
Wong, Reynold C., Roger Silvestrini, Judy Savige, David A. Fulcher, & Elizabeth M. Benson. (1999). Diagnostic value of classical and atypical antineutrophil cytoplasmic antibody (ANCA) immunofluorescence patterns.. Journal of Clinical Pathology. 52(2). 124–128. 24 indexed citations
18.
Savige, Judy, Bill Paspaliaris, Roger Silvestrini, et al.. (1998). A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies.. Journal of Clinical Pathology. 51(8). 568–575. 58 indexed citations
19.
Verge, Charles F., N. J. Howard, Ilja Hulinsky, et al.. (1994). Anti-glutamate decarboxylase and other antibodies at the onset of childhood IDDM: a population-based study. Diabetologia. 37(11). 1113–1120. 16 indexed citations
20.
Verge, Charles F., N. J. Howard, Merrill J. Rowley, et al.. (1994). Anti-glutamate decarboxylase and other antibodies at the onset of childhood IDDM: a population-based study. Diabetologia. 37(11). 1113–1120. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F. Maurier Breakdown of academic impact, for papers by E. L. Matteson Breakdown of academic impact, for papers by Curry L. Koening Breakdown of academic impact, for papers by Lillian Barra Breakdown of academic impact, for papers by R. Pérez-Álvarez Breakdown of academic impact, for papers by Cándido Díaz‐Lagares Breakdown of academic impact, for papers by J. Schmidt Breakdown of academic impact, for papers by José María Pego‐Reigosa Breakdown of academic impact, for papers by M J Cuadrado Breakdown of academic impact, for papers by Sung Soo Ahn
Rankless by CCL
2026